Unit:
|
Logistics Industry Department of Investment Promotion Committee, Pingtan Comprehensive Experimental Zone
|
![]() |
Project Area:
|
pingtan Pingtan Cross-Strait Medical and Health Industrial Park; Haixi (West Coast) Entry-Exit Animal-Plant Quarantine Center; Drug Safety Evaluation Center (Laboratory Animal Center)
|
|
Industry:
|
Biological and New Pharmaceutical Industry
|
|
Type of Project:
|
New Project
|
|
Cooperation Mode:
|
Collaborate
|
|
Nature of Project:
|
Encourage
|
|
Working Progress in Prior Period:
|
none
|
|
Total Investment:
|
discussed in detai
|
|
Expected to Attract Investment:
|
discussed in detai
|
|
Benefit Analysis:
|
none
|
|
Reason and Condition:
|
none
|
|
Content and Scale:
|
1. Pingtan Cross-Strait Medical and Health Industrial Park: plans to introduce enterprises of biomedical R&D, production and sales for imports and exports of drugs, medical devices and cosmetics, as well as headquarter logistics, bonded R&D, and bonded processing.2. Haixi (West Coast) Entry-Exit Animal-Plant Quarantine Center: plans to introduce third-party technical service platforms for disease models of laboratory animals, non-clinical safety research on drugs and medical devices, testing, and drug screening and evaluation.3. Drug Safety Evaluation Center: plans to introduce third-party technical service platforms engaging in disease models of laboratory animals, non-clinical safety research on drugs and medical devices, testing, and drug screening and evaluation.
|
|
Others:
|
none
|
Biological & New Pharmaceutical Industry
In 2024, Fujian Province had 344 pharmaceutical enterprises above designated size, generating a total revenue of RMB 60.84 billion. Our province has established a relatively comprehensive pharmaceutical industrial system, covering categories such as chemical APIs (active pharmaceutical ingredients), chemical drug preparations, biopharmaceuticals, traditional Chinese medicine (TCM) preparations, TCM decoction pieces, and medical devices. The biopharmaceutical industry in Fujian Province is primarily concentrated in Xiamen, Sanming, Fuzhou, and Zhangzhou, with these four cities accounting for approximately 80% of our province's total revenue.